MoneyWorks4Me

Guj. Inject (Kerala) - Quaterly Results

06 Nov 2023 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2023, as compared to corresponding quarter of last year.Net profit of the cmpany stood at Rs. 0.12 millions for the quarter ended September 2023 a decline of -53.85% from Rs. 0.26 millions  in the same quarter last year.Operating Profit reported a sharp decline to 0.16 millions from 0.36 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.00 0.32 0.00 1.54 0.73 110.96 1.74 0.23 656.52
Other Income 0.23 4.00 -94.25 0.23 4.03 -94.29 4.33 0.48 802.08
PBIDT 0.16 0.36 -55.56 0.53 0.42 26.19 0.55 0.04 1275.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.16 0.36 -55.56 0.53 0.42 26.19 0.55 0.04 1275.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.16 0.36 -55.56 0.53 0.42 26.19 0.55 0.04 1275.00
TAX 0.04 0.10 -60.00 0.14 0.12 16.67 0.14 0.01 1300.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.12 0.26 -53.85 0.39 0.30 30.00 0.41 0.03 1266.67
Equity 48.85 48.85 0.00 48.85 48.85 0.00 48.85 48.85 0.00
PBIDTM(%) 0.00 112.50 0.00 34.42 57.53 -40.18 31.61 17.39 81.75
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..